Cirrus Therapeutics
News,Biotech / MedTech,Singapore
Temasek’s ClavystBio backs UK biotech Cirrus Therapeutics’s $11M funding
Cirrus Therapeutics, an United Kingdom-based ocular immunology-focused biotech, announced Wednesday the close of an $11 million seed financing to advance its pipeline of gene and cell therapies aimed at improving quality of life and extending the ocular healthspan of patients with chronic blinding diseases.
October 3, 2025
Maybank lowers Sea’s earnings on softer margin
October 24, 2025
Partners Group exits Singapore-headquartered Apex Logistics
October 24, 2025
Maybank lowers Sea’s earnings on softer margin
October 24, 2025
Partners Group exits Singapore-headquartered Apex Logistics
October 24, 2025




